A 32-Nucleotide Exon-Splicing Enhancer Regulates Usage of Competing 5′ Splice Sites in a Differential Internal Exon

REFERENCES

• Amendt, B., D. Hesslein, L. J. Chang, and C. M. Stoltzfus. 1994. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 14:3960–3970.
   PubMedGoogle Scholar
• Ban, T., K. Ishimura, H. Fujita, K. Sobue, and S. Kakiuchi. 1984. 2. Immunocytochemical demonstration for caldesmon and actin in the striated and smooth muscle cells and non-muscular cells of various organs of rats. Acta Histochem. Cytochem. 17:331–338.
   Google Scholar
• Bretscher, A., and W. Lynch. 1985. Identification and localization of immu-noreactive forms of caldesmon in smooth and nonmuscle cells: a comparison with the distributions of tropomyosin and α-actinin. J. Cell Biol. 100:1656–1663.
   PubMed Web of Science ®Google Scholar
• Brunak, S., and J. Engelbrecht. 1991. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J. Mol. Biol. 220:49–65.
   PubMed Web of Science ®Google Scholar
• Caputi, M., G. Casari, S. Guenz, R. Tagliabue, A. Sidoli, C. A. Melo, and F. E. Baralle. 1994. A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. Nucleic Acids Res. 22:1018–1022.
   PubMedGoogle Scholar
• Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745–2752.
   PubMed Web of Science ®Google Scholar
• Chen, I.-T., and L. A. Chasin. 1993. Direct selection for mutations affecting splice sites in a hamster dihydrofolate reductase minigene. Mol. Cell. Biol. 13:289–300.
   PubMedGoogle Scholar
• Dingus, J., S. Hwo, and J. Bryan. 1986. Identification by monoclonal antibodies and characterization of human platelet caldesmon. J. Cell Biol. 102: 1748–1757.
   PubMed Web of Science ®Google Scholar
• Dirksen, W. P., R. K. Hampson, S. Qiang, and F. M. Rottman. 1994. A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA. J. Biol. Chem. 269:6431–6436.
   PubMedGoogle Scholar
• Dominski, Z., and R. Kole. 1991. Selection of splice sites in pre-mRNAs with short internal exons. Mol. Cell. Biol. 11:6075–6083.
   PubMed Web of Science ®Google Scholar
• Eperon, I. C., D. C. Ireland, R. A. Smith, A. Mayeda, and A. R. Krainer. 1993. Pathways for selection of 59 splice sites by U1 snRNPs and SF2/ASF. EMBO J. 12:3607–3617.
   PubMedGoogle Scholar
• Eperon, L. P., I. R. Graham, A. D. Griffiths, and I. C. Eperon. 1988. Effects of RNA secondary structure on alternative splicing of pre-mRNA: is folding limited to a region behind the transcribing RNA polymerase? Cell 54:393–401.
   PubMed Web of Science ®Google Scholar
• Estes, P. A., N. E. Cooke, and S. A. Liebhaber. 1992. A native RNA structure controls alternative splice site selection and generates two human growth hormone isoforms. J. Biol. Chem. 267:14902–14908.
   PubMed Web of Science ®Google Scholar
• Frid, M. G., B. V. Shekhonin, V. E. Koteliansky, and M. A. Glukhova. 1992. Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. Dev. Biol. 153:185–193.
   PubMed Web of Science ®Google Scholar
• Fu, X.-D., R. A. Kats, A. M. Skalka, and T. Maniatis. 1991. The role of branchpoint and 39-exon sequences in the control of balanced splicing of avian retrovirus RNA. Genes Dev. 5:211–220.
   PubMedGoogle Scholar
• Fu, X.-D., A. Mayeda, T. Maniatis, and A. R. Krainer. 1992. General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 59 and 39 splice site selection. Proc. Natl. Acad. Sci. USA 89: 11224–11228.
   PubMed Web of Science ®Google Scholar
• Furdon, P. J., and R. Kole. 1988. The length of the downstream exon and the substitution of specific sequences affect pre-mRNA splicing in vitro. Mol. Cell. Biol. 8:860–866.
   PubMedGoogle Scholar
• Glukhova, M. A., M. G. Frid, and V. E. Koteliansky. 1990. Developmental changes in expression of contractile and cytoskeletal proteins in human aortic smooth muscle. J. Biol. Chem. 265:13042–13046.
   PubMed Web of Science ®Google Scholar
• Glukhova, M. A., A. E. Kabakov, M. G. Frid, O. I. Ornatsky, A. M. Belkin, D. N. Mukhin, A. N. Orekhov, V. E. Koteliansky, and V. N. Smirnov. 1988. Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc. Natl. Acad. Sci. USA 85:9542–9546.
   PubMedGoogle Scholar
• Glukhova, M. A., A. E. Kabakov, O. I. Ornatsky, T. D. Vasilevskaya, V. E. Koteliansky, and V. N. Smirnov. 1987. Immunoreactive forms of caldesmon in cultivated human vascular smooth muscle cells. FEBS Lett. 218:292–294.
   PubMedGoogle Scholar
• Haruna, M., K. Hayashi, H. Yano, O. Takeuchi, and K. Sobue. 1993. Common structural and expressional properties of vertebrate caldesmon genes. Biochem. Biophys. Res. Commun. 197:145–153.
   PubMedGoogle Scholar
• Hawkins, J. D. 1988. A survey on intron and exon lengths. Nucleic Acids Res. 16:9893–9908.
   PubMed Web of Science ®Google Scholar
• Hayashi, K., H. Yano, T. Hashida, R. Takeuchi, O. Takeda, K. Asada, E. Takahashi, I. Kato, and K. Sobue. 1992. Genomic structure of the human caldesmon gene. Proc. Natl. Acad. Sci. USA 89:12122–12126.
   PubMed Web of Science ®Google Scholar
• Hoshijima, K., K. Inoue, I. Higuchi, H. Sakamoto, and Y. Shimura. 1991. Control of doublesex alternative splicing by transformer and transformer-2 in Drosophila. Science 252:833–836.
   PubMedGoogle Scholar
• Humphrey, M. B., and J. Bryan. 1992. Human caldesmon isoforms are generated by an unusual alternative splicing mechanism, abstr. 234. In Abstracts of the American Society for Cell Biology Thirty Second Annual Meeting. American Society for Cell Biology, Bethesda, Md.
   Google Scholar
• Humphrey, M. B., H. Herrera-Sosa, G. Gonzalez, R. Lee, and J. Bryan. 1992. Cloning of cDNAs encoding human caldesmons. Gene 112:197–204.
   PubMedGoogle Scholar
• Kakiuchi, R., M. Inui, K. Morimoto, K. Kanda, K. Sobue, and S. Kakiuchi. 1983. Caldesmon, a calmodulin-binding protein, is present in aorta, uterus, and platelets. FEBS Lett. 154:351–356.
   PubMedGoogle Scholar
• Kakizuka, A., T. Ingi, T. Murai, and S. Nakanishi. 1990. A set of U1 snRNA-complementary sequences involved in governing alternative RNA splicing of the kininogen genes. J. Biol. Chem. 265:10102–10108.
   PubMedGoogle Scholar
• Kats, R. A., and A. M. Skalka. 1990. Control of retroviral RNA splicing through maintenance of suboptimal processing signals. Mol. Cell. Biol. 10: 696–704.
   PubMedGoogle Scholar
• Kitamura, N., H. Kitagawa, D. Fukushima, Y. Takagaki, T. Miyata, and S. Nakanishi. 1985. Structural organization of the human kininogen gene and a model for its evolution. J. Biol. Chem. 260:8610–8617.
   PubMed Web of Science ®Google Scholar
• Krainer, A. R., G. C. Conway, and D. Kozak. 1990. The essential pre-mRNA splicing factor SF2 influences 59 splice site selection by activating proximal sites. Cell 62:35–42.
   PubMed Web of Science ®Google Scholar
• Laviqueur, A., H. La Branche, A. R. Kornblihtt, and B. Chabot. 1993. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev. 7:2405–2417.
   PubMedGoogle Scholar
• Libri, D., A. Piseri, and M. Y. Fiszman. 1991. Tissue-specific splicing in vivo of the β-tropomyosin gene: dependence on an RNA secondary structure. Science 252:1842–1845.
   PubMed Web of Science ®Google Scholar
• Litchfield, D. W., and E. H. Ball. 1987. Phosphorylation of caldesmon 77 by protein kinase C in vitro and in intact human platelets. J. Biol. Chem. 262:8056–8060.
   PubMed Web of Science ®Google Scholar
• Mar, J. H., P. B. Antin, T. A. Cooper, and C. P. Ordahl. 1988. Analysis of the upstream regions governing expression of the chicken cardiac tropinin T gene in embryonic cardiac and skeletal muscle cells. J. Cell Biol. 107:573–585.
   PubMedGoogle Scholar
• Marston, S. 1989. Calcium ion-dependent regulation of uterine smooth muscle thin filaments by caldesmon. Am. J. Obstet. Gynecol. 160:252–257.
   PubMedGoogle Scholar
• Marston, S. B., and W. Lehman. 1985. Caldesmon is a Ca21-regulatory component of native smooth-muscle thin filaments. Biochem. J. 231:517–552.
   PubMed Web of Science ®Google Scholar
• Marston, S. B., and C. S. Redwood. 1991. The molecular anatomy of caldes-mon. Biochem. J. 279:1–16.
   PubMed Web of Science ®Google Scholar
• Mayeda, A., D. H. Helfman, and A. R. Krainer. 1993. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol. Cell. Biol. 13:2993–3001.
   PubMed Web of Science ®Google Scholar
• Mayeda, A., and A. R. Krainer. 1992. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 68:365–375.
   PubMed Web of Science ®Google Scholar
• Nelson, K. K., and M. R. Green. 1990. Mechanism for cryptic splice site activation during pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 87:6253–6257.
   PubMedGoogle Scholar
• Oshima, Y., and Y. Gotoh. 1987. Signals for the selection of a splice site in pre-mRNA. J. Mol. Biol. 195:247–259.
   PubMedGoogle Scholar
• Owada, M. K., A. Hakura, K. Iida, I. Yahara, K. Sobue, and S. Kakiuchi. 1984. Occurrence of caldesmon (a calmodulin-binding protein) in cultured cells: comparison of normal and transformed cells. Proc. Natl. Acad. Sci. USA 81:3133–3137.
   PubMed Web of Science ®Google Scholar
• Ramchatesingh, J., A. M. Zahler, K. M. Neugebauer, M. B. Roth, and T. Cooper. Submitted for publication.
   Google Scholar
• Robberson, B. L., G. J. Cote, and S. M. Berget. 1990. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol. Cell. Biol. 10:84–94.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Sobue, K., Y. Muramoto, M. Fujita, and S. Kakiuchi. 1981. Purification of a calmodulin-binding protein from chicken gizzard that interacts with F-actin. Proc. Natl. Acad. Sci. USA 78:5652–5655.
   PubMed Web of Science ®Google Scholar
• Sobue, K., and J. R. Sellers. 1991. Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. J. Biol. Chem. 266: 12115–12118.
   PubMed Web of Science ®Google Scholar
• Solnick, D. 1985. Alternative splicing caused by RNA secondary structure. Cell 43:667–676.
   PubMed Web of Science ®Google Scholar
• Solnick, D., and S. I. Lee. 1987. Amount of RNA secondary structure required to induce an alternative splice. Mol. Cell. Biol. 7:3194–3198.
   PubMed Web of Science ®Google Scholar
• Staknis, D., and R. Reed. 1994. SR proteins promote the first specific recognition of pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol. Cell. Biol. 14:7670–7682.
   PubMed Web of Science ®Google Scholar
• Sterner, D. A., and S. M. Berget. 1993. In vivo recognition of a vertebrate mini-exon as an exon-intron-exon unit. Mol. Cell. Biol. 13:2677–2687.
   PubMedGoogle Scholar
• Streuli, M., and H. Saito. 1989. Regulation of tissue-specific alternative splicing: exon-specific cis-elements govern the splicing of leukocyte common antigen pre-mRNA. EMBO J. 8:787–796.
   PubMedGoogle Scholar
• Sun, Q., A. Mayeda, R. K. Hampson, A. R. Krainer, and F. M. Rottman. 1993. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 7:2598–2608.
   PubMed Web of Science ®Google Scholar
• Takagaki, Y., N. Kitamura, and S. Nakanishi. 1985. Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight prekininogens. J. Biol. Chem. 260:8601–8609.
   PubMed Web of Science ®Google Scholar
• Tanaka, K., A. Watakabe, and Y. Shimura. 1994. Polypurine sequences within a downstream exon function as a splicing enhancer. Mol. Cell. Biol. 4:1347–1354.
   Google Scholar
• Tian, M., and T. Maniatis. 1993. A splicing enhancer complex controls alternative splicing of doublesex pre-mRNA. Cell 74:105–114.
   PubMedGoogle Scholar
• Tian, M., and T. Maniatis. 1994. A splicing enhancer exhibits both constitutive and regulated activities. Genes Dev. 8:1703–1712.
   PubMedGoogle Scholar
• Tsukahara, T., C. Casciato, and D. M. Helfman. 1994. Alternative splicing of β-tropomyosin pre-mRNA: multiple cis-elements can contribute to the use of the 59- and 39-splice sites of the nonmuscle/smooth muscle exon 6. Nucleic Acids Res. 22:2318–2325.
   PubMedGoogle Scholar
• Ueki, N., K. Sobue, K. Kanda, T. Hada, and K. Higashino. 1987. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc. Natl. Acad. Sci. USA 84:9049–9053.
   PubMed Web of Science ®Google Scholar
• Wakamatsu, N., H. Kobayashi, T. Miyatake, and S. Tsuji. 1992. A novel exon mutation in the human β-hexosaminidase β subunit gene affects 39 splice site selection. J. Biol. Chem. 267:2406–2413.
   PubMedGoogle Scholar
• Wang, C.- L. A., J. M. Chalovich, P. Graceffa, R. C. Lu, K. Mabuchi, and W. F. Stafford. 1991. A long helix from the central region of smooth muscle caldesmon. J. Biol. Chem. 266:13958–13963.
   PubMed Web of Science ®Google Scholar
• Watakabe, A., K. Inoue, H. Sakamoto, and Y. Shimura. 1989. A secondary structure at the 39 splice site affects the in vitro splicing reaction of mouse immunoglobulin m chain pre-mRNAs. Nucleic Acids Res. 17:8159–8169.
   PubMedGoogle Scholar
• Watakabe, A., K. Tanaka, and Y. Shimura. 1993. The role of exon sequences in splice site selection. Genes Dev. 7:407–418.
   PubMed Web of Science ®Google Scholar
• Wu, J. Y., and T. Maniatis. 1993. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 75:1061–1070.
   PubMed Web of Science ®Google Scholar
• Xie, W., and L. I. Rothblum. 1991. Rapid, small-scale RNA isolation from tissue culture cells. BioTechniques 11:325–327.
   Web of Science ®Google Scholar
• Xu, R., J. Teng, and T. A. Cooper. 1993. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol. Cell. Biol. 13:3660–3674.
   PubMedGoogle Scholar
• Yamashiro, S., Y. Yamakita, H. Hosoya, and F. Matsumura. 1991. Phos-phorylation of non-muscle caldesmon by p34cdc2 kinase during mitosis. Nature (London) 349:169–172.
   PubMed Web of Science ®Google Scholar
• Yang, X., M. R. Bani, S. J. Lu, S. Rowan, Y. Ben-David, and B. Chabot. 1994. The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 59 splice site selection in vivo. Proc. Natl. Acad. Sci. USA 91:6924–6928.
   PubMedGoogle Scholar
• Yano, H., K. Hayashi, M. Haruna, and K. Sobue. 1994. Identification of two distinct promoters in the chicken caldesmon gene. Biochem. Biophys. Res. Commun. 201:618–626.
   PubMed Web of Science ®Google Scholar
• Zahler, A. M., K. M. Neugebbauer, W. S. Lane, and M. B. Roth. 1993. Distinct functions of SR proteins in alternative splicing. Science 260:219–222.
   PubMed Web of Science ®Google Scholar
• Zamore, P. D., J. G. Patton, and M. R. Green. 1992. Cloning and domain structure of the mammalian splicing factor U2AF. Nature (London) 355: 609–614.
   PubMed Web of Science ®Google Scholar